Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
29.3%
% of XPH's 41 holdings also in PPH
50.0%
% of PPH's 27 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ZOETIS INC | 3.7% | 4.6% | 3.7% |
|
JOHNSON & JOHNSON | 3.7% | 6.6% | 3.7% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% | 4.5% | 3.7% |
|
ELI LILLY & CO | 3.7% | 11.9% | 3.7% |
|
PFIZER INC | 3.6% | 4.4% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PPH
|
TARSUS PHARMACEUTICALS, INC. | 3.9% |
|
INTRA-CELLULAR THERAPIES INC | 3.7% |
|
CORCEPT THERAPEUTICS INC | 3.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 3.6% |
|
ROYALTY PHARMA PLC CLASS A | 3.5% |
|
EDGEWISE THERAPEUTICS, INC. | 3.2% |
 |
PERRIGO CO | 2.9% |
|
PACIRA PHARMACEUTICALS INC | 2.9% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | 2.8% |
|
ELANCO ANIMAL HEALTH, INC. | 2.7% |
XPH Underweight Relative to PPH
|
ELI LILLY & CO | -8.2% |
|
ABBVIE INC | -6.5% |
 |
NOVARTIS AG-ADR | -5.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -4.9% |
|
CENCORA INC | -4.9% |
 |
SANOFI-AVENTIS-ADR | -4.9% |
|
MCKESSON CORP | -4.7% |
 |
NOVO-NORDISK A/S-SPONS ADR | -4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% |